Clinical trial
Prospective, Non-interventional Study for the Recording of Adherence to Treatment With Perindopril/Indapamide/Amlodipine Fixed Dose Combination, in a Greek Population With Hypertension
NCT02655029 is registered in ClinicalTrials.gov with Servier Hellas Pharmaceuticals Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Non-interventional Study for the Recording of Adherence to Treatment With Perindopril/Indapamide/Amlodipine Fixed Dose Combination, in a Greek Population With Hypertension
- Lead sponsor
- Servier Hellas Pharmaceuticals Ltd.
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 25, 2015
- Completion date
- December 21, 2016
- Enrollment
- 2,285 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adherence to medication regime, hypertensive disease